Clinical Trials Browser

Phase 2 × Multiple Myeloma × Semaxinib × Clear all

NCT00006013 2013-07-11

SU5416 in Treating Patients With Refractory or Relapsed Multiple Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell